<bill session="117" type="s" number="2187" updated="2023-03-08T20:12:14Z">
  <state datetime="2021-06-23">REFERRED</state>
  <status>
    <introduced datetime="2021-06-23"/>
  </status>
  <introduced datetime="2021-06-23"/>
  <titles>
    <title type="official" as="introduced">A bill to establish the "Biomedical Innovation Fund", and for other purposes.</title>
    <title type="display">National Biomedical Research Act</title>
    <title type="short" as="introduced">National Biomedical Research Act</title>
  </titles>
  <sponsor bioguide_id="W000817"/>
  <cosponsors>
    <cosponsor bioguide_id="B001230" joined="2021-06-23"/>
    <cosponsor bioguide_id="B001277" joined="2021-06-23"/>
    <cosponsor bioguide_id="B001288" joined="2021-06-23"/>
    <cosponsor bioguide_id="C000141" joined="2021-06-23"/>
    <cosponsor bioguide_id="C001070" joined="2021-06-23"/>
    <cosponsor bioguide_id="D000622" joined="2021-06-23"/>
    <cosponsor bioguide_id="K000384" joined="2021-06-23"/>
    <cosponsor bioguide_id="L000570" joined="2021-06-23"/>
    <cosponsor bioguide_id="M000133" joined="2021-06-23"/>
    <cosponsor bioguide_id="M001169" joined="2021-06-23"/>
    <cosponsor bioguide_id="P000145" joined="2021-06-23"/>
    <cosponsor bioguide_id="S000033" joined="2021-06-23"/>
    <cosponsor bioguide_id="V000128" joined="2021-06-23"/>
  </cosponsors>
  <actions>
    <action datetime="2021-06-23">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2021-06-23" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="4124" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Aging"/>
    <term name="Appropriations"/>
    <term name="Budget deficits and national debt"/>
    <term name="Cancer"/>
    <term name="Child health"/>
    <term name="Computers and information technology"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Education programs funding"/>
    <term name="Environmental health"/>
    <term name="Executive agency funding and structure"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Genetics"/>
    <term name="Government trust funds"/>
    <term name="Health care costs and insurance"/>
    <term name="Health information and medical records"/>
    <term name="Health personnel"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Immunology and vaccination"/>
    <term name="Medicaid"/>
    <term name="Medical education"/>
    <term name="Medical research"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Medicare"/>
    <term name="Military medicine"/>
    <term name="Minority health"/>
    <term name="National Institutes of Health (NIH)"/>
    <term name="Neurological disorders"/>
    <term name="Nutrition and diet"/>
    <term name="Physical fitness and lifestyle"/>
    <term name="Poverty and welfare assistance"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments/>
  <summary date="2021-12-16T17:59:30Z" status="Introduced in Senate">National Biomedical Research Act

This bill establishes and makes deposits through FY2030 into the Biomedical Innovation Fund for initiatives at the National Institutes of Health and the Food and Drug Administration. The fund supports (1) research for disease prevention, diagnosis, and treatment; (2) research for diseases that disproportionally account for federal health care spending; (3) the development, review, and post-market surveillance of medical products; and (4) other innovative medical research.</summary>
</bill>
